Ifrah Financial Services, Inc.
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1382646
Little Rock, AR
Position in HALO
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$545,854
+$91,570 QoQ
Shares Held
6,974
-0.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#381
of 664 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ifrah Financial Services, Inc. holds $2,383,535 across 3 Biotechnology names. HALO ranks #2 (22.9% of the industry book) .
All Filings in HALO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $545,854 | 6,974 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $454,284 | 7,029 | Shares | Sole | 2026-04-22 | |
| 2023-12-31 | $223,977 | 6,060 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $245,664 | 6,431 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $234,346 | 6,497 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $251,557 | 6,587 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $384,131 | 6,751 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $277,649 | 7,022 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $310,112 | 7,048 | Shares | Sole | 2022-08-05 | |
| No filing history on record for this holder in this stock. | ||||||